The BMJ article, near the end, reports that the FDA actually did investigate and did find issues with the trial.
> An FDA review memorandum released in August this year states that across the full trial swabs were not taken from 477 people with suspected cases of symptomatic covid-19.
Of course, this comes after insinuating earlier that there is a complete lack of oversight.
> “There’s just a complete lack of oversight of contract research organisations and independent clinical research facilities,” says Jill Fisher, professor of social medicine at the University of North Carolina School of Medicine and author of Medical Research for Hire: The Political Economy of Pharmaceutical Clinical Trials.
I guess since you yourself were misled according to their own inconsistencies, maybe that is enough to convince you that the article is misleading.
I don't know what FDA review memorandum involves but it doesn't sound that the FDA did investigation. It could be simply that the FDA checked submitted documentation from that site and concluded this because the CRO hadn't provided any test results.
Sorry, I don't see any inconsistencies. The box clearly explains what they mean by complete lack of oversight – doing inspections many months after the trial and even then just checking the paperwork.
> An FDA review memorandum released in August this year states that across the full trial swabs were not taken from 477 people with suspected cases of symptomatic covid-19.
Of course, this comes after insinuating earlier that there is a complete lack of oversight.
> “There’s just a complete lack of oversight of contract research organisations and independent clinical research facilities,” says Jill Fisher, professor of social medicine at the University of North Carolina School of Medicine and author of Medical Research for Hire: The Political Economy of Pharmaceutical Clinical Trials.
I guess since you yourself were misled according to their own inconsistencies, maybe that is enough to convince you that the article is misleading.